<GlossaryTerm id="CDR0000782188"><TermName>Gleostine</TermName><TermPronunciation>(GLEE-oh-steen)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat brain tumors that have already been treated with surgery or radiation therapy and Hodgkin lymphoma that got worse after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Gleostine damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called CCNU and lomustine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000786389" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Gleostine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000802519" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Gleostine&quot;" language="es" id="_4"/><SpanishTermName>Gleostine</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de tumores de encéfalo tratados con cirugía o radioterapia, además se usa para el linfoma de Hodgkin que empeoró después del tratamiento con otros medicamentos contra el cáncer. También está en estudio para el tratamiento de otros tipos de cáncer. Gleostine daña el ADN de las células y es posible que destruya células cancerosas. Es un tipo de alquilante y de nitrosourea. También se llama CCNU y lomustina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2016-07-11</DateFirstPublished><DateLastModified>2020-12-21</DateLastModified><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000725247" url="/about-cancer/treatment/drugs/lomustine">Lomustine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
